AARTIDRUGS — Aarti Drugs Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	24,886	27,161	25,286	23,870	25,653
Cost of Revenue
Gross Profit	5,212	5,146	5,316	5,292	9,466
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	22,061	24,569	22,590	21,526	23,231
Operating Profit	2,825	2,591	2,696	2,344	2,422
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,700	2,242	2,355	2,118	2,109
Provision for Income Taxes
Net Income After Taxes	2,050	1,664	1,716	1,681	1,949
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,050	1,663	1,714	1,682	1,949
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,050	1,663	1,714	1,682	1,949
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	22.1	18	18.7	18.4	21.4
Dividends per Share